Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brunner

Showing results (361-370 of 905) with videos related to

Pageof 91
Sort By:
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
True versus immunoreactive angiotensin II in human plasmaJ Nussberger, D B Brunner, B Waeber, et al.
Lancet (London, England)|August 10, 1974
Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881H Gavras, H R Brunner, I Gavras, et al.
Cardiovascular Research|July 1, 1995
Vascular acetylcholine response during chronic NO synthase inhibition: in vivo versus in vitroA Zanchi, J F Aubert, H R Brunner, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1984
Measurement of low angiotensin concentrations after ethanol and Dowex extraction proceduresJ Nussberger, D B Brunner, B Waeber, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1984
[Therapy of retinal vascular disorders by modification of blood viscosity--a randomized double-blind study]R Brunner, A Heinen, W Konen, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1984
Human angiotensin I competes with two non-thiol converting enzyme inhibitors (CGS 13934 & MK-422) to inhibit the angiotensin-converting enzyme activity of human plasmaD S Chen, J Nussberger, H R Brunner, et al.
Pharmacological Reviews|March 15, 2013
A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonistsMartin C Michel, Carolyn Foster, Hans R Brunner, et al.
British Journal of Clinical Pharmacology|December 3, 1999
Evaluation of noninvasive blood pressure recording by photoplethysmography in clinical studies using angiotensin challengesT Buclin, C Buchwalder-Csajka, H R Brunner, et al.
British Journal of Clinical Pharmacology|December 3, 1999
Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin systemC Buchwalder-Csajka, T Buclin, H R Brunner, et al.
Progress in Biochemical Pharmacology|January 1, 1976
Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balanceH R Brunner, H Gavras, A B Ribeiro, et al.
Pageof 91

Showing results (361-370 of 905) with videos related to

Sort By:
Pageof 91
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
True versus immunoreactive angiotensin II in human plasmaJ Nussberger, D B Brunner, B Waeber, et al.
Lancet (London, England)|August 10, 1974
Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881H Gavras, H R Brunner, I Gavras, et al.
Cardiovascular Research|July 1, 1995
Vascular acetylcholine response during chronic NO synthase inhibition: in vivo versus in vitroA Zanchi, J F Aubert, H R Brunner, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1984
Measurement of low angiotensin concentrations after ethanol and Dowex extraction proceduresJ Nussberger, D B Brunner, B Waeber, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1984
[Therapy of retinal vascular disorders by modification of blood viscosity--a randomized double-blind study]R Brunner, A Heinen, W Konen, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1984
Human angiotensin I competes with two non-thiol converting enzyme inhibitors (CGS 13934 & MK-422) to inhibit the angiotensin-converting enzyme activity of human plasmaD S Chen, J Nussberger, H R Brunner, et al.
Pharmacological Reviews|March 15, 2013
A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonistsMartin C Michel, Carolyn Foster, Hans R Brunner, et al.
British Journal of Clinical Pharmacology|December 3, 1999
Evaluation of noninvasive blood pressure recording by photoplethysmography in clinical studies using angiotensin challengesT Buclin, C Buchwalder-Csajka, H R Brunner, et al.
British Journal of Clinical Pharmacology|December 3, 1999
Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin systemC Buchwalder-Csajka, T Buclin, H R Brunner, et al.
Progress in Biochemical Pharmacology|January 1, 1976
Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balanceH R Brunner, H Gavras, A B Ribeiro, et al.
Pageof 91